Literature DB >> 10650167

Differential down-regulation of the human delta-opioid receptor by SNC80 and [D-Pen(2),D-Pen(5)]enkephalin.

T Okura1, S M Cowell, E Varga, T H Burkey, W R Roeske, V J Hruby, H I Yamamura.   

Abstract

We examined the contribution of the human delta-opioid receptor carboxyl terminal tail to (+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2, 5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC80)- and cyclic[D-Pen(2),D-Pen(5)]enkephalin (DPDPE)-mediated receptor down-regulation. Both SNC80 and DPDPE mediated down-regulation of an epitope tagged human delta-opioid receptor. Truncation of the human delta-opioid receptor after Gly(338) blocked DPDPE-mediated down-regulation. However, SNC80 mediated significant down-regulation of the truncated receptor. These findings suggest that SNC80-mediated down-regulation involves receptor domains in addition to the carboxyl terminal tail.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10650167     DOI: 10.1016/s0014-2999(99)00761-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Plasmon resonance studies of agonist/antagonist binding to the human delta-opioid receptor: new structural insights into receptor-ligand interactions.

Authors:  Z Salamon; S Cowell; E Varga; H I Yamamura; V J Hruby; G Tollin
Journal:  Biophys J       Date:  2000-11       Impact factor: 4.033

2.  Ligand modulation of lateral segregation of a G-protein-coupled receptor into lipid microdomains in sphingomyelin/phosphatidylcholine solid-supported bilayers.

Authors:  Isabel D Alves; Zdzislaw Salamon; Victor J Hruby; Gordon Tollin
Journal:  Biochemistry       Date:  2005-06-28       Impact factor: 3.162

Review 3.  Design of peptide and peptidomimetic ligands with novel pharmacological activity profiles.

Authors:  Victor J Hruby; Minying Cai
Journal:  Annu Rev Pharmacol Toxicol       Date:  2013       Impact factor: 13.820

4.  Differential behavioral tolerance to the delta-opioid agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley rats.

Authors:  Emily M Jutkiewicz; Sarah T Kaminsky; Kenner C Rice; John R Traynor; James H Woods
Journal:  J Pharmacol Exp Ther       Date:  2005-07-13       Impact factor: 4.030

5.  Adenosine A(1) receptor agonist N(6)-cyclohexyl-adenosine induced phosphorylation of delta opioid receptor and desensitization of its signaling.

Authors:  Yun Cheng; Yi-min Tao; Jian-feng Sun; Yu-hua Wang; Xue-jun Xu; Jie Chen; Zhi-qiang Chi; Jing-gen Liu
Journal:  Acta Pharmacol Sin       Date:  2010-06-21       Impact factor: 6.150

6.  Endomorphin-1 induced desensitization and down-regulation of the recombinant mu-opioid receptor.

Authors:  C Harrison; D J Rowbotham; D K Grandy; D G Lambert
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.